Attention Bias Modification Versus Attention Control in Treatment of Social Anxiety
NCT ID: NCT05018260
Last Updated: 2023-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2021-05-01
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Attention Bias Modification Treatment (ABMT) and Cognitive-Behavioral Group Therapy (CBGT) in Social Anxiety Disorder
NCT02338453
Gaze Contingent Feedback for Anxiety Disorders in Children
NCT03171363
Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety
NCT03016052
Attention Bias Modification Training for Social Phobia (ABMSP)
NCT06054386
CBT vs. ABM vs. for Social Anxiety
NCT01909193
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GCMRT
Attention bias modification: participants will receive gaze-contingent feedback according to their viewing patterns on disgusted and neutral faces
Attention Bias Modification
Feedback according to participants' viewing patterns, in order to modify their attention bias to threat
attention control
Attention control modification: participants will receive gaze-contingent feedback according to their viewing patterns on rounded and sharp geometric shapes
Attention Control
Feedback according to participants' viewing patterns, in order to strengthen their attention control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attention Bias Modification
Feedback according to participants' viewing patterns, in order to modify their attention bias to threat
Attention Control
Feedback according to participants' viewing patterns, in order to strengthen their attention control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women between the ages of 18 and 65.
* Meeting a current diagnosis of Social Anxiety Disorder (SP) according to the DSM-IV.
* SP as the primary diagnosis: In cases of co-morbidity, SP will be deemed as the most distressing and clinically significant condition among the co-morbid disorders.
* No current pharmaco-therapy.
Exclusion Criteria
* A diagnosis of a neurological disorder (i.e., epilepsy, brain injury).
* Drug or alcohol abuse.
* Any current pharmacological treatment.
* Any current psychotherapeutic treatment.
* Change in treatment during the study.
* Poor judgment capacity (i.e., children under 18 and special populations).
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel Aviv University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yair Bar-Haim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yair Bar-Haim, PhD
Role: PRINCIPAL_INVESTIGATOR
Tel Aviv University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv University
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TAUAttentionControl
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.